BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 24477096)

  • 1. Overall cardiovascular prognosis of isolated systolic hypertension, isolated diastolic hypertension and pulse pressure defined with home measurements: the Finn-home study.
    Niiranen TJ; Rissanen H; Johansson JK; Jula AM
    J Hypertens; 2014 Mar; 32(3):518-24. PubMed ID: 24477096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study.
    Niiranen TJ; Hänninen MR; Johansson J; Reunanen A; Jula AM
    Hypertension; 2010 Jun; 55(6):1346-51. PubMed ID: 20385970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice.
    Fagard RH; Van Den Broeke C; De Cort P
    J Hum Hypertens; 2005 Oct; 19(10):801-7. PubMed ID: 15959536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study.
    Johansson JK; Niiranen TJ; Puukka PJ; Jula AM
    Hypertension; 2012 Feb; 59(2):212-8. PubMed ID: 22215704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.
    Clement DL; De Buyzere ML; De Bacquer DA; de Leeuw PW; Duprez DA; Fagard RH; Gheeraert PJ; Missault LH; Braun JJ; Six RO; Van Der Niepen P; O'Brien E;
    N Engl J Med; 2003 Jun; 348(24):2407-15. PubMed ID: 12802026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal schedule for home blood pressure measurement based on prognostic data: the Finn-Home Study.
    Niiranen TJ; Johansson JK; Reunanen A; Jula AM
    Hypertension; 2011 Jun; 57(6):1081-6. PubMed ID: 21482956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Office, home, and ambulatory blood pressures as predictors of cardiovascular risk.
    Niiranen TJ; Mäki J; Puukka P; Karanko H; Jula AM
    Hypertension; 2014 Aug; 64(2):281-6. PubMed ID: 24842916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Johansson J; Jula AM
    J Hypertens; 2012 Apr; 30(4):705-12. PubMed ID: 22278146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
    Salles GF; Cardoso CR; Muxfeldt ES
    Arch Intern Med; 2008 Nov; 168(21):2340-6. PubMed ID: 19029499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are blood pressure and diabetes additive or synergistic risk factors? Outcome in 8494 subjects randomly recruited from 10 populations.
    Sehestedt T; Hansen TW; Li Y; Richart T; Boggia J; Kikuya M; Thijs L; Stolarz-Skrzypek K; Casiglia E; Tikhonoff V; Malyutina S; Nikitin Y; Björklund-Bodegård K; Kuznetsova T; Ohkubo T; Lind L; Torp-Pedersen C; Jeppesen J; Ibsen H; Imai Y; Wang J; Sandoya E; Kawecka-Jaszcz K; Staessen JA
    Hypertens Res; 2011 Jun; 34(6):714-21. PubMed ID: 21307869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama study.
    Inoue R; Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hirose T; Hara A; Hoshi H; Hashimoto J; Totsune K; Satoh H; Kondo Y; Imai Y
    Am J Hypertens; 2007 Oct; 20(10):1125-31. PubMed ID: 17903698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study.
    Hozawa A; Ohkubo T; Nagai K; Kikuya M; Matsubara M; Tsuji I; Ito S; Satoh H; Hisamichi S; Imai Y
    Arch Intern Med; 2000 Nov; 160(21):3301-6. PubMed ID: 11088093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study.
    Hansen TW; Jeppesen J; Rasmussen S; Ibsen H; Torp-Pedersen C
    Am J Hypertens; 2006 Mar; 19(3):243-50. PubMed ID: 16500508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal number of days for home blood pressure measurement.
    Niiranen TJ; Asayama K; Thijs L; Johansson JK; Hara A; Hozawa A; Tsuji I; Ohkubo T; Jula AM; Imai Y; Staessen JA;
    Am J Hypertens; 2015 May; 28(5):595-603. PubMed ID: 25399016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.